Companies: 10,795·Total market cap: $144.5T
Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc.

CATXAMEXHealthcare● Active
$2.94
$-0.10(-3.14%)
Market Cap$226728750
P/E Ratio
52W High$6.16
52W Low$1.96

Perspective Therapeutics, Inc. (CATX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · CATX · as of Jun 8, 2026

Activity summary

Buy transactions

8

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Perspective Therapeutics, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

CATX insider buying and selling by quarter

CATX insider selling · CATX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
61.0M30.5M0
2025 Q1
2025 Q3
2025 Q4
2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · CATX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

CATX executive sell shares · CATX board member insider trading · CATX insider trading SEC filing

Showing 45 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Hunt Jonathan Robert

CAO

Purchase

Date

Nov 13

Shares

11,000

Price

$2.03

Value

$22K

View Form 4 on SEC.gov

Williamson Robert F III

Director

Purchase

Date

Nov 12

Shares

9,498

Price

$2.10

Value

$20K

View Form 4 on SEC.gov

Spoor Johan M.

CEO · Director

Purchase

Date

Mar 28

Shares

22,026

Price

$2.24

Value

$49K

View Form 4 on SEC.gov

Spoor Johan M.

CEO · Director

Purchase

Date

Mar 28

Shares

4,650

Price

$2.21

Value

$10K

View Form 4 on SEC.gov

Williamson Robert F III

Director

Purchase

Date

Mar 31

Shares

38,145

Price

$2.14

Value

$82K

View Form 4 on SEC.gov

Williamson Robert F III

Director

Purchase

Date

Mar 28

Shares

22,192

Price

$2.27

Value

$50K

View Form 4 on SEC.gov

Graham Juan

CFO

Purchase

Date

Mar 28

Shares

33,333

Price

$2.25

Value

$75K

View Form 4 on SEC.gov

Woods Lori A

Director

Purchase

Date

Mar 31

Shares

23,475

Price

$2.13

Value

$50K

View Form 4 on SEC.gov

HENSON HEIDI

Director

Purchase

Date

Dec 4

Shares

25,975

Price

$3.85

Value

$100K

View Form 4 on SEC.gov

Spoor Johan M.

CEO · Director

Purchase

Date

Dec 4

Shares

8,000

Price

$3.77

Value

$30K

View Form 4 on SEC.gov

Williamson Robert F III

Director

Purchase

Date

Nov 25

Shares

2,619

Price

$3.67

Value

$10K

View Form 4 on SEC.gov

Williamson Robert F III

Director

Purchase

Date

Nov 25

Shares

3,647

Price

$3.62

Value

$13K

View Form 4 on SEC.gov

Hunt Jonathan Robert

CFO

Purchase

Date

Nov 25

Shares

10,000

Price

$3.88

Value

$39K

View Form 4 on SEC.gov

Hunt Jonathan Robert

CFO

Purchase

Date

Nov 25

Shares

2,400

Price

$3.60

Value

$9K

View Form 4 on SEC.gov

Hunt Jonathan Robert

CFO

Purchase

Date

Nov 25

Shares

29

Price

$3.94

Value

$114

View Form 4 on SEC.gov

Hunt Jonathan Robert

CFO

Purchase

Date

Nov 25

Shares

400

Price

$3.55

Value

$1K

View Form 4 on SEC.gov

Spoor Johan M.

CEO · Director

Purchase

Date

Nov 25

Shares

14,500

Price

$3.78

Value

$55K

View Form 4 on SEC.gov

Spoor Johan M.

CEO · Director

Purchase

Date

Nov 25

Shares

6,600

Price

$3.80

Value

$25K

View Form 4 on SEC.gov

Spoor Johan M.

CEO · Director

Purchase

Date

Nov 25

Shares

5,400

Price

$3.80

Value

$21K

View Form 4 on SEC.gov

Hunt Jonathan Robert

CFO

Purchase

Date

Jun 17

Shares

1,800

Price

$9.81

Value

$18K

View Form 4 on SEC.gov

Woods Lori A

Director

Purchase

Date

Jun 14

Shares

83

Price

$10.80

Value

$896

View Form 4 on SEC.gov

Woods Lori A

Director

Purchase

Date

Jun 14

Shares

4,504

Price

$10.90

Value

$49K

View Form 4 on SEC.gov

Spoor Johan M.

CEO · Director

Purchase

Date

Jun 13

Shares

100,000

Price

$1.17

Value

$117K

View Form 4 on SEC.gov

Woods Lori A

Director

Purchase

Date

Jun 3

Shares

34,246

Price

$1.46

Value

$50K

View Form 4 on SEC.gov

Hunt Jonathan Robert

CFO

Purchase

Date

May 31

Shares

12,000

Price

$1.40

Value

$17K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About CATX insider trading

CATX insider trades

Perspective Therapeutics, Inc. (CATX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Hunt Jonathan Robert (CAO), Williamson Robert F III (Director). Over the past 12 months, 2 insiders have filed transactions with the SEC. CATX insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Perspective Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

CATX insider trading · 5 questions

The insiders of Perspective Therapeutics, Inc. (CATX) include executives and directors such as Hunt Jonathan Robert (CAO), Williamson Robert F III (Director), among others. Over the past 12 months, 2 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

CATX board member insider tradingwho are CATX insidersCATX insider rosterPerspective Therapeutics, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026